Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3-targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first-ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, pleas
Sí: Apellis Pharmaceuticals tiene ahora mismo 15 vacantes abiertas en JobsRadar, repartidas en 3 departamentos y 5 ubicaciones. 1 de ellas se abrieron en los últimos 30 días. 11 de ellas indican el salario, con una mediana de $169,000 al año. Última actualización el 29 de octubre de 2026 a las 00:47 UTC.